Alzforum Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
bfe67bb53c3c532ef4237fa3323691ae27404769
| Full Name | Alzheimer's Research Forum |
| Type | Research Organization |
| Founded | 2002 |
| Headquarters | Cambridge, MA, USA |
ALZFORUM (Alzheimer's Research Forum) is a premier online community and resource for Alzheimer's disease (AD) researchers. Founded in 2002, ALZFORUM provides a platform for scientific collaboration, data sharing, and discussion of emerging research findings in the field of neurodegeneration.
The organization operates ALZFORUM.org, which serves as a comprehensive hub for the Alzheimer's research community, offering:
- Peer-reviewed research updates
- Drug discovery pipelines
- Research tools and reagents databases
- Community forums for scientific discussion
- Conference announcements and proceedings
¶ Mission and Activities
ALZFORUM facilitates collaboration among Alzheimer's researchers worldwide by:
- Hosting webinars and virtual meetings
- Organizing research working groups
- Coordinating multi-site studies
- Connecting basic scientists with clinical researchers
A comprehensive database tracking:
- Clinical Trials: Over 200+ AD clinical trials including failed, ongoing, and completed
- Failed Drug Candidates: Detailed analysis of why treatments failed
- Preclinical Compounds: Early-stage therapeutic candidates
- Target Engagement Data: Biomarker and mechanism of action data
Essential tools for AD researchers:
- Antibodies: Validated antibodies for AD-related proteins (Aβ, tau, APOE)
- Mouse Models: APP/PS1, 3xTg-AD, 5xFAD, Tau P301S and other models
- Cell Lines: Primary neurons, iPSC-derived neurons, glial cells
- Software Tools: Analysis pipelines, visualization tools
ALZFORUM publishes:
- Research Highlights: Timely commentary on new publications
- Review Articles: Comprehensive summaries of research areas
- Editorial Perspectives: Expert opinions on emerging research directions
- Conference Proceedings: Abstracts and summaries from major meetings
ALZFORUM promotes open science practices in AD research through:
- Data Sharing Platforms: Collaborative repositories for datasets
- Reproducibility Initiatives: Validation of key findings
- Pre-registration: Encouraging study pre-registration
- Open Access: Supporting open-access publishing
The organization maintains comprehensive records:
- Trial Status: Real-time tracking of recruitment and enrollment
- Outcome Data: Published and unpublished trial results
- Biomarker Studies: CSF, PET, and blood-based biomarker data
- Patient Registries: Connecting patients with trials
- Expert Directories: Contact information for AD researchers
- Collaborative Projects: Matching researchers for studies
- Mentorship Programs: Connecting junior and senior investigators
ALZFORUM has significantly influenced AD research:
- Accelerating Communication: Reduced barriers between researchers worldwide
- Drug Development Tracking: Comprehensive pipeline analysis informed by over 1,000 compounds
- Identifying Research Gaps: Highlighted underexplored therapeutic targets
- Fostering Collaborations: Enabled hundreds of multi-institutional studies
- Education: Training the next generation of AD researchers
Regular online seminars featuring:
- Leading AD researchers
- Novel therapeutic approaches
- Clinical trial updates
- Methodological innovations
- Young Investigator Awards
- Travel fellowships to conferences
- Innovation grants
- Standardizing AD research methodologies
- Cross-laboratory validation studies
- Consensus guidelines development
ALZFORUM contributors have published in premier journals:
- Nature Neuroscience
- Neuron
- Alzheimer's & Dementia
- Journal of Neuroscience
- Brain
- Nature Medicine
| Metric |
Value |
| Registered Users |
50,000+ |
| Publications Tracked |
100,000+ |
| Clinical Trials Listed |
200+ |
| Research Resources |
5,000+ |
| Webinar Attendees |
10,000+ annually |
The study of Alzforum Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.